ADMA FY 2015 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+21.3% YoY

Gross Profit

$3M39.9% margin

Operating Income

-$16M-216.1% margin

Net Income

-$18M-250.4% margin

EPS (Diluted)

$-1.73

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$24M

Total Liabilities

$23M

Stockholders' Equity

$820,974

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+21.3%
Gross Profit	$3M	$2M	+31.9%
Operating Income	-$16M	-$16M	+3.2%
Net Income	-$18M	-$17M	-6.9%